Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: Do direct-acting antiviral regimens matter?

Hepatology. 2018 Mar;67(3):1180-1182. doi: 10.1002/hep.29701. Epub 2018 Jan 30.

Fanpu Ji^{1

2

3}, Yee Hui Yeo¹, Mike Tzuhen Wei¹, Bin Wei¹, Shuangsuo Dang², Zongfang Li^{3

4}, Mindie H Nguyen¹

¹ Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA.
² Department of Infectious Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
³ Shaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
⁴ National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

No abstract available

Publication types